Behavior shifts Driving forces shift behaviors New patient journey Emerging GTM model Enhanced value and evidence requirements Potential behavior shifts Magnitude of disruption No major shift expected Potentially to be highly disruptive Patients Personal health engagement; Technology adoption Providers Restricted rep access; Increased tele-health adoption Public payers Reallocation of budget from drugs to health services Private payers Consideration of integration, consolidation. Investment in innovation. Hospitals Shifted role of hospitals; Opening of new treatment centers Pharmacy More e-Pharmacy; Increase in home-delivery IQVIA Global Executive Briefing: COVID-19 June 2020; Copyright 2020 IQVIA. 22